Vericel is a biopharmaceutical firm that develops and commercializes autologous cell therapies for the treatment of severe diseases.
Business Model:
Revenue: $159.3M
Employees: 201-500
Address: 64 Sidney Sreet
City: Cambridge
State: MA
Zip: 02139
Country: US
Vericel is a biopharmaceutical firm that develops and commercializes autologous cell therapies for the treatment of severe diseases.
Contact Phone:
+16175885555
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/4/1997
Ticker Symbol:
VCEL
IPO Price:
$7/share
Amount Raised:
$21M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2018 | Post-IPO Equity | $74.8M | 3/2012 | Post-IPO Equity | 1 | $40M |
Eastern Capital Eastern Capital |
12/2017 | Debt | $15M |
Silicon Valley Bank MidCap Financial |
12/2016 | Post-IPO Equity | $20M | 2/1997 | IPO | $21M |
|
3/2012 | Equity | $40M | 3/2016 | Debt | $15M |
Silicon Valley Bank Silicon Valley Bank |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|